Rtw Investments as of March 31, 2019
Portfolio Holdings for Rtw Investments
Rtw Investments holds 50 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 19.1 | $280M | 16M | 17.47 | |
| Ptc Therapeutics I (PTCT) | 6.5 | $95M | 2.5M | 37.64 | |
| Dicerna Pharmaceuticals | 6.2 | $91M | 6.2M | 14.65 | |
| Alnylam Pharmaceuticals (ALNY) | 5.3 | $78M | 836k | 93.45 | |
| Bristol Myers Squibb (BMY) | 5.0 | $73M | 1.5M | 47.71 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 3.5 | $52M | 3.7M | 13.87 | |
| Masimo Corporation (MASI) | 3.4 | $50M | 364k | 138.28 | |
| Homology Medicines | 3.3 | $48M | 1.7M | 27.73 | |
| Vericel (VCEL) | 3.0 | $44M | 2.5M | 17.51 | |
| Livanova Plc Ord (LIVN) | 2.9 | $42M | 435k | 97.25 | |
| Achillion Pharmaceuticals | 2.8 | $41M | 14M | 2.96 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $40M | 338k | 119.19 | |
| Myokardia | 2.5 | $37M | 707k | 51.99 | |
| Axonics Modulation Technolog (AXNX) | 2.5 | $37M | 1.5M | 23.95 | |
| Adverum Biotechnologies | 2.2 | $33M | 6.3M | 5.24 | |
| Establishment Labs Holdings Ord (ESTA) | 2.2 | $32M | 1.3M | 24.04 | |
| Agenus | 2.0 | $29M | 9.9M | 2.97 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.9 | $28M | 1.5M | 18.35 | |
| Regenxbio Inc equity us cm (RGNX) | 1.8 | $26M | 451k | 57.31 | |
| D Fluidigm Corp Del (LAB) | 1.8 | $26M | 1.9M | 13.29 | |
| Si-bone (SIBN) | 1.6 | $24M | 1.3M | 18.84 | |
| Mirati Therapeutics | 1.6 | $23M | 312k | 73.30 | |
| Concert Pharmaceuticals I equity | 1.4 | $20M | 1.7M | 12.07 | |
| Arbutus Biopharma (ABUS) | 1.4 | $20M | 5.5M | 3.58 | |
| Apyx Medical Corporation (APYX) | 1.4 | $20M | 3.1M | 6.31 | |
| Orthopediatrics Corp. (KIDS) | 1.3 | $19M | 428k | 44.23 | |
| Wave Life Sciences (WVE) | 1.2 | $17M | 437k | 38.85 | |
| Principia Biopharma | 1.1 | $16M | 456k | 34.00 | |
| Translate Bio | 0.9 | $14M | 1.4M | 10.19 | |
| Arvinas Ord (ARVN) | 0.9 | $14M | 917k | 14.76 | |
| Johnson & Johnson (JNJ) | 0.8 | $12M | 85k | 139.79 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $10M | 965k | 10.75 | |
| Uniqure Nv (QURE) | 0.6 | $9.2M | 154k | 59.65 | |
| Myriad Genetics (MYGN) | 0.6 | $8.9M | 268k | 33.20 | |
| Axsome Therapeutics (AXSM) | 0.6 | $8.5M | 596k | 14.23 | |
| Odonate Therapeutics Ord | 0.5 | $7.3M | 331k | 22.11 | |
| Caredx (CDNA) | 0.5 | $7.0M | 222k | 31.52 | |
| Chardan Healthcare Acquisition | 0.4 | $6.0M | 600k | 10.03 | |
| Oncocyte | 0.3 | $5.1M | 1.3M | 3.95 | |
| Viveve Med | 0.3 | $4.2M | 4.5M | 0.94 | |
| Argenx Se (ARGX) | 0.3 | $3.8M | 31k | 124.83 | |
| Electrocore | 0.2 | $3.6M | 518k | 7.00 | |
| Vivus Inc conv | 0.2 | $3.1M | 4.0M | 0.78 | |
| Neuronetics (STIM) | 0.2 | $2.5M | 167k | 15.25 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $1.9M | 301k | 6.43 | |
| Motus Gi Hldgs Incorporated | 0.1 | $1.8M | 460k | 3.90 | |
| Solid Biosciences | 0.1 | $1.3M | 142k | 9.20 | |
| Viewray (VRAYQ) | 0.1 | $1.2M | 159k | 7.39 | |
| Optinose (OPTN) | 0.1 | $851k | 83k | 10.30 | |
| Anchiano Therapeutics | 0.0 | $411k | 60k | 6.80 |
